Efficacy and safety in sitagliptin therapy for diabetes complicated by non-alcoholic fatty liver disease.
Arase Y, Kawamura Y, Seko Y, Kobayashi M, Suzuki F, Suzuki Y, Akuta N, Kobayashi M, Sezaki H, Saito S, Hosaka T, Ikeda K, Kumada H, Ohmoto-Sekine Y, Hsieh SD, Amakawa K, Ogawa K, Matsumoto N, Iwao A, Tsuji H, Hara S, Mori Y, Okubo M, Sone H, Kobayashi T.
Arase Y, et al. Among authors: okubo m.
Hepatol Res. 2013 Nov;43(11):1163-8. doi: 10.1111/hepr.12077. Epub 2013 Mar 12.
Hepatol Res. 2013.
PMID: 23489256